126 related articles for article (PubMed ID: 1455161)
1. Effect of lovastatin on lipoprotein fluidity in patients with hypercholesterolaemia.
Levy Y; Klein L; Aviram M; Brook GJ; Cogan U
Scand J Clin Lab Invest; 1992 Nov; 52(7):671-7. PubMed ID: 1455161
[TBL] [Abstract][Full Text] [Related]
2. Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia.
Levy Y; Leibowitz R; Aviram M; Brook JG; Cogan U
Br J Clin Pharmacol; 1992 Nov; 34(5):427-30. PubMed ID: 1467138
[TBL] [Abstract][Full Text] [Related]
3. Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Jacob BG; Möhrle W; Richter WO; Schwandt P
Eur J Clin Pharmacol; 1992; 42(4):353-8. PubMed ID: 1516599
[TBL] [Abstract][Full Text] [Related]
4. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
Forti N; Ramires JA
Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.
Weintraub MS; Eisenberg S; Breslow JL
Eur J Clin Invest; 1989 Oct; 19(5):480-5. PubMed ID: 2511025
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
Richter WO; Jacob BG; Schwandt P
Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
[TBL] [Abstract][Full Text] [Related]
7. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
[TBL] [Abstract][Full Text] [Related]
8. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
11. Effects of pancreas transplantation on distribution and composition of plasma lipoproteins.
Föger B; Königsrainer A; Palos G; Ritsch A; Tröbinger G; Menzel HJ; Lechleitner M; Doblinger A; König P; Utermann G; Margreiter R; Patsch JR
Metabolism; 1996 Jul; 45(7):856-61. PubMed ID: 8692021
[TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins.
Nakandakare E; Garcia RC; Rocha JC; Sperotto G; Oliveira HC; Quintão EC
Atherosclerosis; 1990 Dec; 85(2-3):211-7. PubMed ID: 2102085
[TBL] [Abstract][Full Text] [Related]
13. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients.
Hochgraf E; Levy Y; Aviram M; Brook JG; Cogan U
Metabolism; 1994 Jan; 43(1):11-7. PubMed ID: 8289667
[TBL] [Abstract][Full Text] [Related]
15. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Franklin FA; Nash DT; Hurley DP; Dujovne CA; Pool JL; Schnaper H; Hesney M
Am J Med; 1991 Jul; 91(1B):18S-24S. PubMed ID: 1867232
[TBL] [Abstract][Full Text] [Related]
16. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
Arca M; Vega GL; Grundy SM
JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
Kerzner B; Corbelli J; Sharp S; Lipka LJ; Melani L; LeBeaut A; Suresh R; Mukhopadhyay P; Veltri EP;
Am J Cardiol; 2003 Feb; 91(4):418-24. PubMed ID: 12586255
[TBL] [Abstract][Full Text] [Related]
18. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels.
Cassader M; Ruiu G; Gambino R; Alemanno N; Veglia F; Pagano G
Atherosclerosis; 1993 Feb; 99(1):47-53. PubMed ID: 8461059
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.
Aviram M; Dankner G; Cogan U; Hochgraf E; Brook JG
Metabolism; 1992 Mar; 41(3):229-35. PubMed ID: 1542259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
